Dow Down 0.57% Nasdaq Down 0.32%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
118.71 Down 1.23(1.03%) 2:22PM EDT - Nasdaq Real Time Price
Prev Close:119.94
Open:120.00
Bid:118.80 x 200
Ask:118.99 x 100
1y Target Est:157.88
Beta:1.12
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:118.64 - 121.20
52wk Range:82.51 - 154.89
Volume:446,821
Avg Vol (3m):988,092
Market Cap:8.94B
P/E (ttm):68.42
EPS (ttm):1.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PCYCDown 1.03%8.94B
CTICDown 0.40%361.13M
MRKDown 0.38%174.09B

Key Statistics

Forward P/E (1 yr):1,698.57
P/S (ttm):20.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.26
Quarterly EPS Est (Sep-14) :0.42
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2,883.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback